So we have a lot of protein based products, we have sports drinks, we have a lot of categories that are balancing each other. The good news for us is I don't think it [weight loss drugs] changes at all the strategy of the company. So if you think about all the vectors of innovation, I was referring to permissibility, functionality, taste, convenience, that remains still. Actually I think we're in a very good place. (19:14–19:18)
CLAIM
Asserts that the emergence of weight loss drugs does not alter the company's strategy.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
